Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuho Tanaka is active.

Publication


Featured researches published by Kazuho Tanaka.


Archive | 2004

2-aminopyrimidine derivatives

Hiroki Sato; Kazuho Tanaka; Makoto Shimazaki; Klaus Urbahns; Katsuya Sakai; Florian Gantner; Kevin Bacon


Archive | 2004

Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani


Archive | 2003

Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2

Kevin Bacon; Yuji Koriyama; Yoshihisa Manabe; Hiroki Sato; Hiromi Sugimoto; Kazuho Tanaka; Klaus Urbahns; Ly Tai Wie; Takashi Yoshino


Archive | 2002

Pyrimido [4,5-b] indole derivatives

Timothy B. Lowinger; Makoto Shimazaki; Hiroki Sato; Kazuho Tanaka; Naoki Tsuno; Karsten Marx; Masaru Yamamoto; Klaus Urbahns; Florian Gantner; Hiromi Okigami; Kosuke Nakashima; Keisuke Takeshita; Kevin Bacon; Hiroshi Komura; Nagahiro Yoshida


Archive | 2006

DERIVADOS DE ACIDO PIRIMIDINILACETICO UTEIS PARA O TRATAMENTO DE DOENCAS MEDIADAS POR CRTH2

Tai Wie Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns


Archive | 2004

Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate For treatment of diseases mediated by CRTH2 suitable pyrimidine

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani


Archive | 2004

For treatment of diseases mediated by CRTH2 suitable pyrimidine

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani


Archive | 2004

Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani


Archive | 2004

Pyrimidine derivatives which are useful for the treatment of CRTH2-mediated diseases

Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Klaus Urbahns; Masanori Seki; Yoshihisa Manabe; Takuya Shintani; Tai-Wei Ly; Kevin Bacon


Archive | 2003

Pyrimidin-acetic acid derivatives useful for the treatment of CRTH2-related diseases

Tai Wie; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns

Collaboration


Dive into the Kazuho Tanaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroki Sato

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroki Sato

Tokyo Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge